Analysis of RNA binding by the dengue virus NS5 RNA capping enzyme.

Search TravelDoctorOnline

Authors: Henderson BR,Saeedi BJ,Campagnola G,Geiss BJ,
Address: Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, United States of America.
Journal: PLoS One.


Publication: 2011;6(10):e25795. doi: 10.1371/journal.pone.0025795. Epub 2011 Oct 12.
Free Text: Analysis of RNA binding by the dengue virus NS5 RNA capping enzyme.

abstract

Flaviviruses are small, capped positive sense RNA viruses that replicate in the cytoplasm of infected cells. dengue virus and other related flaviviruses have evolved RNA capping enzymes to form the viral RNA cap structure that protects the viral genome and directs efficient viral polyprotein translation. The N-terminal domain of NS5 possesses the methyltransferase and guanylyltransferase activities necessary for forming mature RNA cap structures. The mechanism for flavivirus guanylyltransferase activity is currently unknown, and how the capping enzyme binds its diphosphorylated RNA substrate is important for deciphering how the flavivirus guanylyltransferase functions. In this report we examine how flavivirus NS5 N-terminal capping enzymes bind to the 5' end of the viral RNA using a fluorescence polarization-based RNA binding assay. We observed that the K(D) for RNA binding is approximately 200 nM Dengue, Yellow Fever, and West Nile virus capping enzymes. Removal of one or both of the 5' phosphates reduces binding affinity, indicating that the terminal phosphates contribute significantly to binding. RNA binding affinity is negatively affected by the presence of GTP or ATP and positively affected by S-adensyl methoninine (SAM). Structural superpositioning of the dengue virus capping enzyme with the Vaccinia virus VP39 protein bound to RNA suggests how the flavivirus capping enzyme may bind RNA, and mutagenesis Analysis of residues in the putative RNA binding site demonstrate that several basic residues are critical for RNA binding. Several mutants show differential binding to 5' di-, mono-, and un-phosphorylated RNAs. The mode of RNA binding appears similar to that found with other methyltransferase enzymes, and a discussion of diphosphorylated RNA binding is presented.



Related Articles
Recognition of RNA cap in the Wesselsbron virus NS5 methyltransferase domain: implications for RNA-capping mechanisms in Flavivirus.
J Mol Biol. 2009
Recognition of RNA cap in the Wesselsbron virus NS5 methyltransferase domain: implications for RNA-capping mechanisms in Flavivirus.
Bollati M, Milani M, Mastrangelo E, Ricagno S, Tedeschi G, Nonnis S, Decroly E, Selisko B, de Lamballerie X, Coutard B, et al. J Mol Biol. 2009 Jan 9; 385(1):140-52. Epub 2008 Oct 19.
Structure and function of flavivirus NS5 methyltransferase.
J Virol. 2007
Structure and function of flavivirus NS5 methyltransferase.
Zhou Y, Ray D, Zhao Y, Dong H, Ren S, Li Z, Guo Y, Bernard KA, Shi PY, Li H. J Virol. 2007 Apr; 81(8):3891-903. Epub 2007 Jan 31.
Structural and functional analysis of methylation and 5'-RNA sequence requirements of short capped RNAs by the methyltransferase domain of dengue virus NS5.
J Mol Biol. 2007
Structural and functional analysis of methylation and 5'-RNA sequence requirements of short capped RNAs by the methyltransferase domain of dengue virus NS5.
Egloff MP, Decroly E, Malet H, Selisko B, Benarroch D, Ferron F, Canard B. J Mol Biol. 2007 Sep 21; 372(3):723-36. Epub 2007 Jul 12.
Review Flavivirus methyltransferase: a novel antiviral target.
Antiviral Res. 2008
Review Flavivirus methyltransferase: a novel antiviral target.
Dong H, Zhang B, Shi PY. Antiviral Res. 2008 Oct; 80(1):1-10. Epub 2008 Jun 5.
Review Chapter 2. New insights into flavivirus nonstructural protein 5.
Adv Virus Res. 2009
Review Chapter 2. New insights into flavivirus nonstructural protein 5.
Davidson AD. Adv Virus Res. 2009; 74:41-101.
Identification of a novel antiviral inhibitor of the flavivirus guanylyltransferase enzyme.
J Virol. 2012
Identification of a novel antiviral inhibitor of the flavivirus guanylyltransferase enzyme.
Stahla-Beek HJ, April DG, Saeedi BJ, Hannah AM, Keenan SM, Geiss BJ. J Virol. 2012 Aug; 86(16):8730-9. Epub 2012 Jun 6.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.